Captor Therapeutics

Publication date: 2023-12-15

Publication time: 15:00

RB ESPI 61/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-12-12

Publication time: 12:40

RB_ESPI 60/2023 Candidate for member of the Supervisory Board of the Company

Publication date: 2023-12-07

Publication time: 19:45

RB_ESPI 59/2023 Notice of convocation of the Extraordinary General Shareholders Meeting and documents related to the Extraordinary General Meeting

Publication date: 2023-12-07

Publication time: 17:30

RB ESPI 58/2023 Shareholder's request to convene a General Meeting of the Company and to include certain items on the agenda

Publication date: 2023-12-06

Publication time: 09:00

RB ESPI 57/2023 Information on research and development progress in the CT-03 project

Publication date: 2023-12-06

Publication time: 08:55

RB ESPI 56/2023 Information on research and development progress in the CT-02 project

Publication date: 2023-11-13

Publication time: 21:40

RB ESPI 55/2023 Information on the status of the Company's projects and submission of phasing applications

Publication date: 2023-11-06

Publication time: 18:20

RB ESPI 54/2023 Announcement of the National Depository for Securities S.A. on the registration in the depository of securities of ordinary bearer shares of series N, O and P

Publication date: 2023-11-03

Publication time: 17:25

RB ESPI 53/2023 Summary of P share subscription - supplement to current report no. 45/2023 of 11 October 2023

Publication date: 2023-10-27

Publication time: 12:45

RB ESPI 51/2023 Communication from the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on the conditional registration of ordinary bearer shares of series P

Publication date: 2023-10-24

Publication time: 22:05

RB ESPI 50/2023 Notification under Article 69 of the Act on Public Offering - change in a significant block of shares

Publication date: 2023-10-23

Publication time: 14:20

RB ESPI 49/2023 Registration of share capital increase and amendments to the Company's Articles of Association

Publication date: 2023-10-19

Publication time: 21:20

RB ESPI 48/2023 Communication from the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on the conditional registration of ordinary bearer shares of series N and O

Publication date: 2023-10-19

Publication time: 20:40

RB ESPI 47/2023 Communication from the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on the conditional registration of the rights to series P ordinary bearer shares

Publication date: 2023-10-13

Publication time: 13:25

RB ESPI 46/2023 Conclusion of service contracts for Phase I clinical trials for the CT-01 project with ICON Clinical Research Limited

Publication date: 2023-10-11

Publication time: 17:30

RB ESPI 45/2023 Summary of P share subscription

Publication date: 2023-09-29

Publication time: 19:20

RB ESPI 44/2023 Allocation of series P ordinary bearer shares of the Company

Publication date: 2023-09-22

Publication time: 23:05

RB ESPI 43/2023 Completion of the book-building process for the offering of new series P bearer shares and determination of the issue price for series P shares

Publication date: 2023-09-21

Publication time: 19:50

RB ESPI 42/2023 Adoption of a resolution by the Management Board on the issue of shares as part of an authorised share capital increase.

Publication date: 2023-09-21

Publication time: 17:55

RB ESPI 41/2023 Commencement of book-building process for the offering of new P series bearer shares and conclusion of the share offering placement agreement.

Publication date: 2023-09-20

Publication time: 11:22

RB ESPI 40/2023 Registration of share capital increase and amendments to the Company's Articles of Association

Publication date: 2023-09-20

Publication time: 11:16

RB ESPI 39/2023 Registration of an amendment to the Company's Articles of Association

Publication date: 2023-09-11

Publication time: 15:55

RB ESPI 38/2023 Conclusion of an annex extending the cooperation with Wedbush Securities Inc.

Publication date: 2023-09-05

Publication time: 16:50

RB ESPI 37/2023 Text of resolutions adopted by the Extraordinary General Meeting on 5 September 2023

Publication date: 2023-08-30

Publication time: 17:25

RB ESPI 36/2023 Completion of subscription for series O shares issued in connection with the Company's employee incentive scheme

Publication date: 2023-08-18

Publication time: 16:30

RB ESPI 35/2023 Registration of share capital increase and amendments to the Company's Articles of Association

Publication date: 2023-08-09

Publication time: 14:05

RB ESPI 33/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-08-08

Publication time: 17:05

RB ESPI 32/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-08-08

Publication time: 17:00

RB ESPI 31/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-08-08

Publication time: 16:55

RB ESPI 30/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-07-25

Publication time: 17:15

RB ESPI 29/2023 Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Publication date: 2023-07-17

Publication time: 17:55

RB ESPI 28/2023 Conclusion of an agreement with the Medical Research Agency for the implementation and funding of a project to develop an oral molecular adhesive drug candidate for the treatment of colorectal cancer

Publication date: 2023-07-07

Publication time: 19:50

RB ESPI 27/2023 Update on terminated grant agreement with NCBiR for CT-02 project

Publication date: 2023-06-28

Publication time: 13:05

RB ESPI 26/2023 List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 26 June 2023

Publication date: 2023-06-26

Publication time: 17:15

RB ESPI 25/2023 Text of resolutions adopted by the Ordinary General Meeting on 26 June 2023

Publication date: 2023-06-20

Publication time: 22:15

RB ESPI 24/2023 Update on the termination of the grant agreement with the NCBiR concerning project CT-02

Publication date: 2023-06-19

Publication time: 17:05

RB ESPI 23/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-06-14

Publication time: 11:45

RB ESPI 22/2023 Recommendation of the Captor Therapeutics project for funding by the Medical Research Agency

Publication date: 2023-06-06

Publication time: 21:29

RB ESPI 21/2023 Information on receipt of a statement on termination of the grant agreement concluded with NCBiR concerning project CT-02

Publication date: 2023-05-30

Publication time: 15:55

RB ESPI 20/2023 Notice convening the Ordinary Shareholders Meeting and documents relating to the Ordinary Shareholders Meeting

Publication date: 2023-05-12

Publication time: 16:06

RB ESPI 19/2023 Registration of an amendment to the Company's Articles of Association

Publication date: 2023-05-11

Publication time: 16:04

RB ESPI 18/2023 Completion of subscription of N-series shares issued in connection with the Company's employee incentive programme

Publication date: 2023-05-05

Publication time: 16:02

RB ESPI 17/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-05-04

Publication time: 15:55

RB ESPI 16/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-05-04

Publication time: 14:05

RB ESPI 15/2023 Information on transaction in Company shares under Article 19 MAR

Publication date: 2023-04-07

Publication time: 15:33

RB ESPI 14/2023 List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 3 April 2023

Publication date: 2023-04-03

Publication time: 13:51

RB ESPI 13/2023 Text of resolutions adopted by the Extraordinary General Meeting on 3 April 2023

Publication date: 2023-03-27

Publication time: 22:15

RB ESPI 12/2023 Information on progress in research and development related to the CT-01, CT-02 and CT-05 projects and information on the molecular targets of these projects

Publication date: 2023-03-22

Publication time: 22:10

RB ESPI 11/2023 Change of the publication date of the separate annual report and consolidated annual report for the financial year 2022

Publication date: 2023-03-14

Publication time: 10:53

RB ESPI 10/2023 Announcement of the National Securities Depository S.A. on the registration of series M ordinary bearer shares in the securities depository

Publication date: 2023-03-09

Publication time: 13:20

RB ESPI 9/2023 Admission and introduction to exchange trading of series M ordinary bearer shares

Publication date: 2023-03-06

Publication time: 19:11

RB ESPI 7/2023 Captor Therapeutics S.A.'s strategic plans for 2023-2025.

Publication date: 2023-03-02

Publication time: 12:13

RB ESPI 6/2023 Completion of subscription for series M shares issued in connection with the implementation of the Company's employee incentive programme

Publication date: 2023-03-02

Publication time: 12:09

RB ESPI 5/2023 Announcement of the Central Securities Depository of Poland on the conditional registration of series M ordinary bearer shares

Publication date: 2023-03-02

Publication time: 11:21

RB ESPI 4/2023 Information on receipt of NCBR's letter of completion for project CT-04

Publication date: 2023-02-14

Publication time: 11:25

RB ESPI 3/2023 Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase

Publication date: 2023-02-10

Publication time: 15:13

RB ESPI 2/2023 Registration of share capital increase and amendments to the Company's Articles of Association

Publication date: 2023-01-17

Publication time: 15:34

RB ESPI 1/2023 Dates of publication of periodic reports in 2023

Investor Relations Captor Therapeutics ®

Current